BridgeBio Pharma, Inc. (BBIO)
74.51
-0.64
(-0.85%)
USD |
NASDAQ |
Dec 15, 16:00
74.48
-0.03
(-0.04%)
After-Hours: 20:00
BridgeBio Pharma Accounts Payable (Quarterly): 18.70M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Pfizer Inc. | 5.024B |
| Alnylam Pharmaceuticals, Inc. | 117.59M |
| Supernus Pharmaceuticals, Inc. | 8.177M |
| Ionis Pharmaceuticals, Inc. | 14.33M |
| Regeneron Pharmaceuticals, Inc. | 903.80M |